Par Drugs and Share Price History and Returns 2019 to 2024
Par Drugs and Chemicals Limited | |||
Symbol: PAR | |||
Price: ₹271.10 | |||
Exchange: NSE | |||
Healthcare -> Drug Manufacturers—Specialty & Generic |
Show Table of Contents
Table of Contents
- 1: Par Drugs and Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Par Drugs and Recent Performance
- 3: Par Drugs and Stock Price Chart From 2019 to 2024
- 4: Par Drugs and Stock Price History Table From 2019 to 2024
- 5: Analyzing the Impact of Investing in Par Drugs and
- 5.1: Par Drugs and Stock Returns In Last 5 Years
- 5.2: Par Drugs and Stock VS FD (Normal) VS FD (Compounding)
Par Drugs and Stock Highlights
As of Thu 14 Nov 2024, Par Drugs and Stock price is ₹271.1 which is ₹53.90 below 52-week high of ₹325 and ₹80.96 above 52-week low of ₹190.14
52-Week High Low
- Par Drugs and 52-Week High is ₹325 occured on Fri 19 Apr 2024
- Par Drugs and 52-Week Low is ₹190.14 occured on Mon 05 Feb 2024
All Time High
- The all-time high or the highest price that Par Drugs and stocks have ever touched was ₹325 and this occurred on Fri 19 Apr 2024.
- The highest closing price at which Par Drugs and stocks have ever closed was ₹305.5 recorded on Mon 04 Nov 2024.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Advertisement
Par Drugs and Recent Performance
Over the past 22 trading days, the value of Par Drugs and's stock has increased by ₹36.11 (+15.37%). On 11 Oct 2024, its one share was worth ₹234.99 and by 14 Nov 2024, the value jumped to ₹271.10. During this period it created a highest high of ₹324.70 and lowest low of ₹218.00.
Below Image represents line chart of daily close price of Par Drugs and, helping you visualize how the price has changed day by day.
Par Drugs and Stock Price Chart From 2019 to 2024
Par Drugs and Stock Price History Table From 2019 to 2024
Advertisement
Year | Par Drugs and | YOY Chg% | ↑High - ↓Low |
---|---|---|---|
2019 | ₹22.05 | - | ↑ ₹28.00 ↓ ₹19.45 |
2020 | ₹36.50 | 65.5% | ↑ ₹37.40 ↓ ₹13.10 |
2021 | ₹201.25 | 451.3% | ↑ ₹310 ↓ ₹31.20 |
2022 | ₹151.05 | -25% | ↑ ₹205 ↓ ₹131 |
2023 | ₹215.70 | 42.8% | ↑ ₹248 ↓ ₹128 |
2024 | ₹271.10 | 25.6% | ↑ ₹278 ↓ ₹270 |
Analyzing the Impact of Investing in Par Drugs and
Par Drugs and Stock price in the year 2019 was ₹22.05. If you had invested ₹10,000 in Par Drugs and Stock in 2019, in 5 years, your investment would have grown to ₹1.22 Lakh by the end of 2024. This represents a positive return of 1,129% from 2019 to 2024, with a compound annual growth rate (CAGR) of 65.1%.
Advertisement
Par Drugs and Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: 310.60 and lowest was: 13.10
- Par Drugs and Stock price in 2019 was 22.05
- By 2024, its stock price rose to 271.10
- It gave a positive return of over 1,129% with a CAGR of 65.1% over the last 5 years
- If you had invested 10,000 in Par Drugs and in 2019 then in 5 years, your investment would have grown to 1.22 Lakh by 2024, which is 12.29 times of your initial investment.
Par Drugs and Stock VS FD (Normal) VS FD (Compounding)
You might wonder which option is better: Par Drugs and stocks, fixed deposits (FDs) or compounding FDs. Let’s compare them and see how they differ.To help you make a well-informed decision, we have prepared a handy table that compares the returns of Par Drugs and Stock with both FD choices over time.
If you invested ₹10,000 each in these 3 options in null:
Year | Par Drugs and Investment | FD Normal Investment | FD Compond Investment |
---|---|---|---|
2019 | ₹10,000 | ₹10,000 | ₹10,000 |
Then today, your investment would have become this much in each option: | |||
2024 | ₹122,734.06 | ₹13,000.00 | ₹13,382.26 |
- Par Drugs and Price Target Tomorrow
- Par Drugs and Price Long Term Target
- Par Drugs and Dividend History
- Par Drugs and Bonus History
Note: The Stock price data displayed on this web page has been adjusted for any bonus Stocks or Stock splits that occurred over time.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.